| Income Statement |
| Total Revenue | 8.84M |
|
| Revenues (USD) | 8.84M |
| Cost of Revenue | 3.76M |
| Gross Profit | 5.08M |
| Operating Expenses | 7.59M |
| Research and Development Expense | 1.66M |
| Selling, General and Administrative Expense | 5.93M |
| Operating Income | -2.51M |
| Interest Expense | 1.25M |
| Income Tax Expense | 52.00K |
| Net Income | -3.71M |
| Net Income Common Stock | -3.71M |
| Net Income Common Stock (USD) | -3.71M |
| Consolidated Income | -3.71M |
| Earnings per Basic Share | -0.17 |
| Earnings per Basic Share (USD) | -0.17 |
| Earnings per Diluted Share | -0.17 |
| Earning Before Interest & Taxes (EBIT) | -2.41M |
| Earning Before Interest & Taxes (USD) | -2.41M |
| Weighted Average Shares | 22.67M |
| Weighted Average Shares Diluted | 22.67M |
| Balance Sheet |
| Cash and Equivalents | 16.22M |
| Cash and Equivalents (USD) | 16.22M |
| Investments | 463.00K |
| Investments Non-Current | 463.00K |
| Trade and Non-Trade Receivables | 4.18M |
| Current Assets | 26.18M |
| Property, Plant & Equipment Net | 17.93M |
| Total Assets | 44.57M |
| Debt Current | 4.42M |
| Total Debt | 15.70M |
| Current Liabilities | 11.68M |
| Debt Non-Current | 11.28M |
| Total Liabilities | 24.81M |
| Accumulated Retained Earnings (Deficit) | -113.91M |
| Shareholders Equity | 19.76M |
| Shareholders Equity (USD) | 19.76M |
| Assets Non-Current | 18.39M |
| Total Debt (USD) | 15.70M |
| Deferred Revenue | 415.00K |
| Inventory | 5.78M |
| Liabilities Non-Current | 13.13M |
| Trade and Non-Trade Payables | 6.04M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 492.00K |
| Net Cash Flow from Financing | -675.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.03M |
| Capital Expenditure | -568.00K |
| Issuance (Repayment) of Debt Securities | -655.00K |
| Net Cash Flow from Investing | -568.00K |
| Net Cash Flow from Operations | -2.79M |
| Effect of Exchange Rate Changes on Cash | 78.00K |
| Share Based Compensation | 456.00K |